Related Experiment Video
Updated: Oct 17, 2025

10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
24.6K
Recurrent deep pyoderma in German Shepherd dogs with underlying ehrlichioses and hypergammaglobulinaemia.
Cerundolo1, De Caprariis1, Manna1
1Istituto di Clinica Medica Veterinaria, Facoltà di Medicina Veterinaria, Università degli Studi di Napoli Federico II, Napoli, Italy.
Veterinary Dermatology
|October 14, 2021
Summary
Recurrent deep pyoderma in German Shepherds linked to Ehrlichia infection. Doxycycline treatment resolved infections and prevented pyoderma recurrence over a 1-2 year follow-up.
Area of Science:
- Veterinary Dermatology
- Canine Infectious Diseases
Background:
- Recurrent deep pyoderma is a common and challenging condition in dogs.
- Antibacterial therapy often fails to provide long-term resolution for pyoderma.
- Concurrent Ehrlichia spp. infection is a potential underlying cause for treatment-resistant pyoderma.
Purpose of the Study:
- To investigate the role of Ehrlichia spp. infection in recurrent deep pyoderma in German Shepherd dogs.
- To evaluate the efficacy of doxycycline monohydrate in treating Ehrlichia-associated pyoderma.
Main Methods:
- Case series describing four German Shepherd dogs with recurrent deep pyoderma.
- Diagnostic workup included hematological and serum biochemical analyses.
- Indirect fluorescent antibody (IFA) testing was used to detect Ehrlichia spp. infection.
- Treatment involved doxycycline monohydrate administration.
Main Results:
- Hematological and biochemical values normalized following doxycycline treatment.
- Indirect fluorescent antibody (IFA) titres for Ehrlichia spp. decreased.
- No pyoderma relapses were observed during a 1-2 year follow-up period.
Conclusions:
- Ehrlichia spp. infection should be considered in cases of recurrent deep pyoderma unresponsive to conventional antibacterial therapy.
- Doxycycline monohydrate is an effective treatment for Ehrlichia-associated pyoderma, leading to long-term resolution.

